Patents by Inventor Jeffrey Joseph Stewart

Jeffrey Joseph Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080220441
    Abstract: X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.
    Type: Application
    Filed: October 10, 2007
    Publication date: September 11, 2008
    Inventors: Eva R. Birnbaum, Andrew T. Koppisch, Sharon M. Baldwin, Benjamin P. Warner, T. Mark McCleskey, Jeffrey Joseph Stewart, Jennifer A. Berger, Michael N. Harris, Anthony K. Burrell
  • Publication number: 20030108945
    Abstract: A method of identifying the primary cellular and molecular targets of female-prevalent autoimmune diseases is presented. The targets are identified by X-chromosome-inactivation patterns of TDC populations. Methods of using these primary cellular and molecular targets as T-cell tolerogens are also presented. Finally, a method is presented for predicting which patients are likely to benefit from treatment methods.
    Type: Application
    Filed: June 1, 2001
    Publication date: June 12, 2003
    Inventor: Jeffrey Joseph Stewart
  • Publication number: 20030023526
    Abstract: Described is a financial debt security for the raising of capital for pharmaceutical R&D. Also described is a method of estimating the value of such a debt security. Also described is a method of estimating the value of a pharmaceutical in research and development.
    Type: Application
    Filed: July 27, 2001
    Publication date: January 30, 2003
    Inventor: Jeffrey Joseph Stewart
  • Patent number: 6337181
    Abstract: An algorithm for determining the viral antigenic protein variants to be used to construct vaccines designed to immunize against variable viral populations (quasispecies) is described. The method entails analyzing multiple nucleotide sequences of viral proteins and identifying those variants that provide selective advantage to the virus. Examples are given for influenza A hemagglutinin 3 and HIV-1 gp120.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: January 8, 2002
    Inventors: Jeffrey Joseph Stewart, Samuel Litwin, Perry Watts